We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOLI
126
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$15.1M 0.19%
800,430
+58,186
+8% +$1.13M
PFE icon
127
Pfizer
PFE
$140B
$15M 0.19%
366,071
-54,449
-13% -$2.16M
BDX icon
128
Becton Dickinson
BDX
$43.1B
$14.9M 0.19%
61,002
+3,571
+6% +$830K
ZION icon
129
Zions Bancorporation
ZION
$10.1B
$14.9M 0.19%
325,793
+29,635
+10% +$1.37M
APD icon
130
Air Products & Chemicals
APD
$66.3B
$14.9M 0.19%
65,905
-3,160
-5% -$654K
LOW icon
131
Lowe's Companies
LOW
$116B
$14.6M 0.18%
144,964
+13,815
+11% +$1.46M
NKTR icon
132
Nektar Therapeutics
NKTR
$2.39B
$14.5M 0.18%
27,283
-1,303
-5% -$653K
TSS
133
DELISTED
Total System Services, Inc.
TSS
$14.3M 0.18%
+112,342
New +$12.3M
RIGL icon
134
Rigel Pharmaceuticals
RIGL
$680M
– –
-247,800
Closed -$5.59M
WP
135
DELISTED
Worldpay, Inc.
WP
$14.2M 0.18%
116,355
+231
+0.2% +$27.4K
HON icon
136
Honeywell
HON
$77.1B
$14.2M 0.18%
86,572
+1,483
+2% +$236K
KMB icon
137
Kimberly-Clark
KMB
$36.4B
$14M 0.17%
105,565
+8,313
+9% +$1.07M
ARWR icon
138
Arrowhead Research
ARWR
$12.1B
$14M 0.17%
529,000
-65,000
-11% -$1.43M
BIO icon
139
Bio-Rad Laboratories Class A
BIO
$8.42B
$13.9M 0.17%
44,790
+1,500
+3% +$449K
HCA icon
140
HCA Healthcare
HCA
$84.8B
$13.5M 0.17%
99,969
+12,036
+14% +$1.52M
SLAB icon
141
Silicon Laboratories
SLAB
$7.15B
$13.4M 0.17%
130,388
-53,730
-29% -$5.18M
ANSS
142
DELISTED
Ansys
ANSS
$13.4M 0.17%
65,656
+39,391
+150% +$7.5M
HIG icon
143
Hartford Financial Services
HIG
$38.5B
$13.4M 0.17%
240,742
-26,001
-10% -$1.37M
APLS
144
DELISTED
Apellis Pharmaceuticals
APLS
$13.3M 0.17%
527,700
– –
QCOM icon
145
Qualcomm
QCOM
$176B
$13.3M 0.17%
175,634
+29,765
+20% +$2.18M
AWK icon
146
American Water Works
AWK
$26.3B
$13.2M 0.16%
114,383
+19,731
+21% +$2.18M
CL icon
147
Colgate-Palmolive
CL
$72.6B
$12.9M 0.16%
167,381
-32,945
-16% -$2.34M
FDC
148
DELISTED
First Data Corporation
FDC
$12.9M 0.16%
478,773
+203,340
+74% +$5.29M
DRI icon
149
Darden Restaurants
DRI
$22.5B
$12.8M 0.16%
105,500
+64,009
+154% +$7.62M
KMI icon
150
Kinder Morgan
KMI
$73.1B
$12.7M 0.16%
611,907
+122,801
+25% +$2.48M
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.